Peddock Capital Advisors LLC continued to hold its stake in Henry Schein, Inc. (NASDAQ:HSIC) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,097 shares of the company’s stock at the end of the second quarter. Peddock Capital Advisors LLC’s holdings in Henry Schein were worth $201,000 at the end of the most recent reporting period.

Other large investors also recently added to or reduced their stakes in the company. DUPONT CAPITAL MANAGEMENT Corp increased its position in Henry Schein by 351.1% in the first quarter. DUPONT CAPITAL MANAGEMENT Corp now owns 43,647 shares of the company’s stock worth $7,419,000 after buying an additional 33,972 shares in the last quarter. Reilly Herbert Faulkner III increased its position in Henry Schein by 3.5% in the first quarter. Reilly Herbert Faulkner III now owns 21,843 shares of the company’s stock worth $3,713,000 after buying an additional 743 shares in the last quarter. Leavell Investment Management Inc. increased its position in Henry Schein by 2.9% in the first quarter. Leavell Investment Management Inc. now owns 14,264 shares of the company’s stock worth $2,424,000 after buying an additional 400 shares in the last quarter. Strs Ohio increased its position in Henry Schein by 0.6% in the first quarter. Strs Ohio now owns 29,412 shares of the company’s stock worth $4,999,000 after buying an additional 171 shares in the last quarter. Finally, Shell Asset Management Co. increased its position in Henry Schein by 9.6% in the first quarter. Shell Asset Management Co. now owns 39,448 shares of the company’s stock worth $6,705,000 after buying an additional 3,454 shares in the last quarter. Institutional investors own 90.60% of the company’s stock.

Henry Schein, Inc. (NASDAQ HSIC) opened at 170.82 on Tuesday. The company has a 50-day moving average of $179.14 and a 200-day moving average of $175.79. The firm has a market capitalization of $13.50 billion, a price-to-earnings ratio of 24.96 and a beta of 1.09. Henry Schein, Inc. has a 1-year low of $146.23 and a 1-year high of $186.99. Henry Schein shares are going to split before the market opens on Friday, September 15th. The 2-1 split was announced on Wednesday, August 16th. The newly created shares will be issued to shareholders after the market closes on Thursday, September 14th.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Tuesday, August 8th. The company reported $1.75 earnings per share for the quarter, beating the consensus estimate of $1.73 by $0.02. The business had revenue of $3.06 billion during the quarter, compared to analysts’ expectations of $3.05 billion. Henry Schein had a return on equity of 19.91% and a net margin of 4.59%. The firm’s revenue for the quarter was up 6.4% compared to the same quarter last year. During the same quarter last year, the business posted $1.64 EPS. On average, equities analysts predict that Henry Schein, Inc. will post $7.27 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: “Peddock Capital Advisors LLC Continues to Hold Position in Henry Schein, Inc. (HSIC)” was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this article on another domain, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark law. The correct version of this article can be accessed at https://www.thecerbatgem.com/2017/08/22/peddock-capital-advisors-llc-continues-to-hold-position-in-henry-schein-inc-hsic.html.

A number of research firms have recently weighed in on HSIC. Zacks Investment Research downgraded shares of Henry Schein from a “buy” rating to a “hold” rating in a report on Wednesday, August 9th. Northcoast Research upgraded shares of Henry Schein from a “neutral” rating to a “buy” rating and set a $218.00 price target on the stock in a report on Monday, August 7th. BidaskClub downgraded shares of Henry Schein from a “hold” rating to a “sell” rating in a report on Wednesday, August 2nd. Jefferies Group LLC restated a “hold” rating and set a $177.00 price target on shares of Henry Schein in a report on Friday, July 21st. Finally, Credit Suisse Group restated a “hold” rating and set a $160.00 price target on shares of Henry Schein in a report on Thursday, July 13th. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and seven have issued a buy rating to the stock. Henry Schein currently has an average rating of “Hold” and an average target price of $185.56.

About Henry Schein

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Stock Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related stocks with our FREE daily email newsletter.